Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 396 publications
Updated Overall Survival Analysis From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 19, 2025
Corrigendum to: A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF-Mutated Thyroid Cancer in Japan.
Journal: Thyroid : official journal of the American Thyroid Association
Published: September 30, 2025
Postmarket review of photosensitivity associated with select BRAF and MEK inhibitors.
Journal: Journal of chemotherapy (Florence, Italy)
Published: August 01, 2025
Real-World Efficacy and Safety of MEK Inhibitor for Patients With Advanced NRAS-Mutant Melanoma: A Single-Center Retrospective Study in Japan.
Journal: The Journal of dermatology
Published: July 28, 2025
A phase IB study of binimetinib and palbociclib in molecularly selected advanced triple-negative breast cancer.
Journal: Cancer research communications
Published: July 25, 2025
COLUMBUS part 1-7-year results for encorafenib and binimetinib in BRAF V600-mutant melanoma.
Journal: Future oncology (London, England)
Published: July 24, 2025
Peripheral neuropathies induced by BRAF+MEK inhibitor combinations: a real-world study based on FAERS database 2011-2022.
Journal: Expert opinion on drug safety
Published: July 04, 2025
Dabrafenib plus trametinib vs encorafenib plus binimetinib in BRAF-mutant metastatic melanoma: a real-world propensity score-matched survival analysis.
Journal: Journal of the National Cancer Institute
Published: June 24, 2025
POLARIS: encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis.
Journal: Future oncology (London, England)
Published: June 12, 2025
Rapid radiological response of leptomeningeal carcinosis and prolonged survival to encorafenib and binimetinib in BRAF-mutated melanoma.
Journal: Anti-cancer drugs
Published: May 29, 2025
Last Updated: 10/31/2025